Received Dec 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (UNKNOWN)) | UNKNOWN MANUFACTURER | 2 | — | OT / LA |
| PPV | PNEUMO (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | OT / LA |
| COVID19 | COVID19 (COVID19 (UNKNOWN)) | UNKNOWN MANUFACTURER | 2 | — | OT / LA |
| PPV | PNEUMO (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | OT / LA |
| PPV | PNEUMO (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | OT / LA |
| PPV | PNEUMO (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | OT / LA |
who experienced lot of fatigue; dizziness; This spontaneous report was received from a 70-year-old male patient reporting on himself. The patient's medical history included SARS-CoV-2 test positive. The patient's concurrent conditions included patient's son and his wife had covid-19 (family history). Historical drugs included RSV vaccine (RSV vaccine), Varicella zoster vaccine (Varicella zoster vaccine), Janssen COVID-19 vaccine (COVID-19 vaccine NRVV Ad26 (JNJ 78436735)), and Novavax COVID-19 Vaccine (COVID-19 vaccine prot. subunit (NVX CoV 2373)). Concomitant therapies were not reported. On 24-SEP-2025, the patient was vaccinated in his left arm, with a dose of pneumococcal Vaccine (could be PNEUMOVAX 23, VAXNEUVANCE or CAPVAXIVE) (strength, dose, route, lot number and expiration date were not provided) as prophylactic vaccination. On the same date, the patient was also vaccinated with a dose of COVID-19 vaccine prot. subunit (NVX CoV 2373) (NOVAVAX) 0.5 mL (strength, dose, route, lot #, expiration date were not reported) as Covid-19 immunization. On unspecified date in September 2025, the patient experienced dizziness and a lot of fatigue. On unspecified date in Septmeber 2025, the patient recovered from both events The reporter considered both events to be related to pneumococcal Vaccine and COVID-19 vaccine prot. subunit (NVX CoV 2373) (NOVAVAX)
Familial risk factor
Medical History/Concurrent Conditions: SARS-CoV-2 infection